Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-04-28 ÀÏ 14:23
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 104°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
¸¸¼ºÁúȯ °ñ´Ù°øÁõ °ñÀý À§Çè, °ñ¹Ðµµ °¨¼Ò ¿¹Ãøº¸´Ù ³ôÀ» ¼ö ÀÖ¾î
¸¸¼ºÁúȯ-°ñ´Ù°øÁõ ¹ß»ý±âÀü¸¸¼ºÁúȯ¿¡¼ ¹ß»ýÇÏ´Â °ñ´Ù°øÁõÀÇ °øÅëÀûÀÎ ¹ß»ý±âÀüÀº ¸¸¼º ¿°Áõ, »êÈ ½ºÆ®·¹½º·Î »ý°¢µÇ°í ÀÖ´Ù. ¶ÇÇÑ ¸¸¼ºÁúȯ...
THE MOST
|
2021-07-02 10:33
¶óÀÎ
[KSCMS]
Ç÷´ç°ÇÏÁ¦ÀÇ ºñ´ç´¢º´ Áúȯ Ä¡·áÁ¦·Î¼ÀÇ ¹Ì·¡
- ¼º±Õ°üÀÇ´ë ÀÌÀºÁ¤ ±³¼ö
¼·ÐÃÖ´ëÀÇ ºí·Ï¹ö½ºÅÍ(blockbuster) ¾à¹°À̾ú´ø ·Î½Ã±Û¸®Å¸Á¸(rosiglitazone)ÀÇ ´ç´¢º´ ½ÃÀå ÅðÃâÀº ´ç´¢º´ ½Å¾àÀÇ ½ÃÀå...
THE MOST
|
2021-06-04 15:39
¶óÀÎ
[Sub Story]
FAST¡¤FANTASTIC Çѱ¹ÀÎ Àӻ󿬱¸ ÁÖ¸ñ
FAST°¡Å縯ÀÇ´ë ÀÓ»óÇö ±³¼ö(°¡Å縯´ëºÎõ¼º¸ðº´¿ø ¼øȯ±â³»°ú)ÆÀÀº ¡®Drug Design, Development and Therapy¡¯...
ÀÌ»óµ· ±âÀÚ
|
2021-05-11 15:17
¶óÀÎ
[Sub Story]
RAS¾ïÁ¦Á¦+ÀÌ´¢Á¦ º´¿ë¡¤º¹ÇÕÁ¦
º´¿ëó¹æ ºñÁß↑´ëÇѹα¹¿¡¼ÀÇ Ç×°íÇ÷¾ÐÁ¦ ó¹æÆÐÅÏ ¿ª½Ã º´¿ë¿ä¹ýÀ¸·Î ¹«°ÔÃß°¡ ±â¿ï°í ÀÖ´Ù. ´ëÇÑ°íÇ÷¾ÐÇÐȸÀÇ °íÇ÷¾Ð Áø·áÁöħ¿¡¼´Â...
ÀÌ»óµ· ±âÀÚ
|
2021-05-11 14:58
¶óÀÎ
[Deep in Guideline]
MET + SGLT-2i 1Â÷ Ä¡·áÀü·«À¸·Î Á¦½Ã
´ç´¢º´ + CKD ÅëÇÕÀû °ü¸®KDIGO´Â ´ç´¢º´°ú CKD¸¦ µ¿¹ÝÇÏ°í Àִ ȯÀÚ¿¡°Ô ½ÅÀåÁúȯ ÁøÇà°ú ½ÉÇ÷°üÁúȯ À§ÇèÀ» °¨¼Ò½ÃÅ°±â À§ÇÑ Åë...
ÀÓ¼¼Çü ±âÀÚ
|
2021-04-16 17:54
¶óÀÎ
[Interview]
¡°½ÉºÎÀü °ü¸®¿¡¼ SGLT-2¾ïÁ¦Á¦ ¿ªÇÒ Ä¿Áú °Í¡±
Q. ±¹³» ½ÉºÎÀü À¯º´·üÀÇ º¯ÈÃßÀÌ°¡ ±Ã±ÝÇÏ´Ù.±¹³» ½ÉºÎÀü À¯º´·üÀº Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÏ°í ÀÖ´Ù. ±¹¹Î°Ç°º¸Çè°ø´Ü ÀÚ·á¿¡ ÀÇÇϸé 2002³â...
ÀÓ¼¼Çü ±âÀÚ
|
2021-04-16 17:52
¶óÀÎ
[Sub Story]
CKD + °íÇ÷¾Ð SBP 120mmHg ¹Ì¸¸À¸·Î
Ç÷¾ÐÃøÁ¤Ç÷¾ÐÀÌ ³ôÀº ¼ºÀΠȯÀÚÀÇ °ü¸®¸¦ À§ÇØ Ç¥ÁØ Áø·á½Ç Ç÷¾Ð ÃøÁ¤¹æ¹ýÀ» ±Ç°íÇß´Ù(1B).È°µ¿Ç÷¾ÐÃøÁ¤(ABPM)À̳ª °¡Á¤Ç÷¾ÐÃøÁ¤(HBP...
ÀÓ¼¼Çü ±âÀÚ
|
2021-04-16 17:52
¶óÀÎ
[Cover Story]
Ç÷¾Ð¡¤Ç÷´çÁ¶Àý ±âÀüÀ¸·Î ½ÉÀ塤½ÅÀåÁúȯ º® Çã¹®´Ù
°íÇ÷¾Ð Ä¡·á Ç×°íÇ÷¾ÐÁ¦½ÉºÎÀüÀÇ ¿¹¹æ¡¤°ü¸®¿¡ ÀÖ¾î °íÇ÷¾Ð Ä¡·á, Áï Ç÷¾ÐÁ¶ÀýÀº ÇʼöºÒ°¡°áÇÏ´Ù. °íÇ÷¾ÐÀÌ ½ÉºÎÀüÀÇ ÁÖ¿ä À§ÇèÀÎÀÚÀ̱⠶§¹®ÀÌ...
ÀÌ»óµ· ±âÀÚ
|
2021-04-16 17:51
¶óÀÎ
[Sub Story]
±¹³» CKD ȯÀÚ 460¸¸¸í ¿¬Æò±Õ 8.7% Áõ°¡ Áß
±¹³» CKD ¿ªÇб¹³» CKD ȯÀÚ¼ö´Â 460¸¸¸íÀ¸·Î ¼ºÀÎ 9¸í Áß 1¸í²ÃÀÌ´Ù. ³²³à ºñÀ²À» ±¸ºÐÇßÀ» ¶§´Â ³²¼º 57%, ¿©¼º 43%·Î ...
ÀÓ¼¼Çü ±âÀÚ
|
2021-04-16 15:45
¶óÀÎ
[Sub Story]
´ç´¢º´ ȯÀÚ Ç÷¾ÐÄ¡·á·Î ½ÅÀåÁúȯ À§Çè±îÁö
´ç´¢º´ ȯÀÚ Ç÷¾ÐÁ¶ÀýADVANCE ¿¬±¸´Â ´ç´¢º´ ȯÀÚ¿¡¼ ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò¾ïÁ¦Á¦(ACEI) Æ丰µµÇÁ¸±°ú ÀÌ´¢Á¦ ÀδÙÆĹ̵åÀÇ °íÁ¤¿ë·® º´...
ÀÌ»óµ· ±âÀÚ
|
2021-04-16 11:55
¶óÀÎ
[Conference Report]
ÇǸ¶»ç¸£Åº ¡®´Ü¹é´¢ °¨¼Ò¡¯ ÀûÀÀÁõ È®´ë ½ÉÇ÷°ü¡¤½ÅÀ庸ȣȿ°ú Á¤Á¶ÁØ
FANTASTIC → ½ÅÀ庸ȣȿ°ú¿¬¼¼ÀÇ´ë ¹Ú¼ºÇÏ ±³¼ö(¼¼ºê¶õ½ºº´¿ø ½ÉÀå³»°ú)´Â ÇǸ¶»ç¸£Åº ¹ß¸Å 10Áֳ⠽ÉÆ÷Áö¿ò¿¡¼ ¡®±Ù°Å¿¡ ...
ÀÌ»óµ· ±âÀÚ
|
2021-04-16 11:50
¶óÀÎ
[Sub Story]
LDL-C ¸ñǥġ ³»·Á°¡´Ï ºñ½ºÅ¸Æ¾°è º´¿ëÀº Up
¸ñǥġ ±âÁØ Ä¡·áAACE¡¤ACE ÀÌ»óÁöÁúÇ÷Áõ °¡À̵å¶óÀÎÀº ¹Ì±¹½ÉÀåÇÐȸ(ACC)¡¤½ÉÀåÇùȸ(AHA)¿Í ´Þ¸® ȯÀÚÀÇ ½ÉÇ÷°üÁúȯ À§Çèµµ¿¡ µû¶ó...
ÀÌ»óµ· ±âÀÚ
|
2021-03-09 13:47
¶óÀÎ
[Sub Story]
Ç÷´ç°ÇÏÁ¦ÀÇ ½ÉÇ÷°ü ÇýÅÃÀº?
½ÉÇ÷°ü¡¤½ÉÀ塤½ÅÀåÁúȯÀ̹ø °¡À̵å¶óÀÎÀÇ ¾Ë°í¸®µë¿¡¼´Â ¾à¹°Ä¡·á 2Â÷¼±Åðú °ü·ÃÇØ Á׻󵿸ưæȼº ½ÉÇ÷°üÁúȯ(ASCVD)¡¤½ÉºÎÀü(HF)¡¤¸¸¼º...
ÀÌ»óµ· ±âÀÚ
|
2021-03-09 10:45
¶óÀÎ
[Sub Story]
1Â÷Ä¡·á¿¡ »ýÈ°¿ä¹ý°ú Ç÷´ç°ÇÏÁ¦
ȯÀÚƯ¼º ºÎÇÕ ¾àÁ¦¼±Åþ๰ġ·á ¾Ë°í¸®µëÀº Å« Ʋ¿¡¼´Â ¿¹³â°ú °°Àº ¸ð¾ç»õ·Î, ¾àÁ¦¼±ÅÃÀÇ °¡Àå Áß¿äÇÑ ±âÁØÀº ȯÀÚ ¹× ¾àÁ¦ÀÇ Æ¯¼ºÀÌ´Ù. ...
ÀÌ»óµ· ±âÀÚ
|
2021-02-02 10:21
¶óÀÎ
[Sub Story]
Ç÷´ç°ÇÏÁ¦ ¼±Åýà °í·Á»çÇ×
ȯÀÚ Á᫐ Á¢±Ù¹ýADA´Â »õ °¡À̵å¶óÀο¡¼ Ç÷´ç°ÇÏÁ¦ Ä¡·áÀü·«À» ¼±ÅÃÇÏ´Â µ¥ ÀÖ¾î, ¸î °¡Áö ±âÁØÀ» Á¦½ÃÇÏ°í ÀÖ´Ù. ÀÌ Áß ´ëÇ¥ÀûÀÎ ±â...
ÀÌ»óµ· ±âÀÚ
|
2021-02-02 10:21
¶óÀÎ
[Cover Story]
¡®2021¡¯ ADA °¡À̵å¶óÀÎ º¸¸é
¡®ÀÌ°øÀÌÀÏ¡¯ ´ç´¢º´ °ü¸®¹æÇâ º¸ÀδÙ
Ä¡·á ¾Ë°í¸®µëADA°¡ °ÇÀÇÇÑ ¿Ã ÇÑÇØ ´ç´¢º´ °ü¸®¹æÇâÀÇ Ç¥ÁØÀº ¡®¾à¹°Ä¡·á(Pharmacologic Approaches to Glycem...
ÀÌ»óµ· ±âÀÚ
|
2021-02-01 18:26
¶óÀÎ
[Sub Story]
CKD ȯÀÚ ½ÉÇ÷°ü À§Çè °ü¸®¿¡µµ SGLT-2I¡¤GLP-1RA ±Ç°í
¼±º°°Ë»çADA´Â Áö¼ÓÀûÀ¸·Î ¸ðµç ´ç´¢º´ ȯÀÚÀÇ ½ÅÀå±â´É Æò°¡¿¡ ¹«°Ô¸¦ µ×°í, ƯÈ÷ ÃßÀû°üÂû¿¡ ´ëÇؼ´Â ±Ç°íµî±ÞÀ» ³ô¿© Á¦½ÃÇß´Ù. À¯º´±â...
ÀÓ¼¼Çü ±âÀÚ
|
2021-02-01 15:40
¶óÀÎ
[Sub Story]
¿¥Æı۸®Ç÷ÎÁø ¡®½ÉºÎÀü¡¤½ÅÀåÁúȯ¡¯ ¾à¹°·Î ÀÚ¸®¸Å±è
½ÉºÎÀüEMPA-REG OUTCOMEADA °¡À̵å¶óÀο¡¼´Â Á½ɽǹÚÃâ·® °¨¼Ò ½ÉºÎÀü(HFrEF) ȯÀÚ¿¡ ´ëÇÑ ¿¥Æı۸®Ç÷ÎÁøÀÇ ´ëÇ¥ÀûÀÎ ±Ù°Å·Î EMPA-REG OUTCOME ¿¬±¸(NEJM. 2015)¸¦ ²Å¾Ò´Ù. EMPA...
ÀÓ¼¼Çü ±âÀÚ
|
2021-02-01 15:39
¶óÀÎ
[Sub Story]
SGLT-2¾ïÁ¦Á¦ÀÇ ¾àÁø...
ASCVD¿¡ À̾î HF¡¤CKD±îÁö
ȯÀÚ¿¡ ÀûÇÕÇÑ ¾àÁ¦Æ¯¼º´ç´¢º´ Ä¡·á¿¡¼ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÏ´Â Àü·«Àº ¹Ù·Î ¾à¹°¿ä¹ýÀÌ´Ù. Çö´Ü°è¿¡¼´Â ¸ÞÆ®Æ÷¸£¹Î, ¼³Æù¿ä¼ÒÁ¦, Ƽ¾ÆÁ¹¸®µòµð¿Â°è(TZD), DPP-4¾ïÁ¦Á¦, SGLT-2¾ïÁ¦Á¦ µîÀÇ °æ±¸Ç÷´ç°ÇÏÁ¦¿Í GL...
ÀÌ»óµ· ±âÀÚ
|
2021-01-04 17:44
¶óÀÎ
[Conference Report]
´ÙÆı۸®Ç÷ÎÁø ¡®½ÅÀå¾à¡¯À¸·Î ÇÕ°ÝÁ¡
½ÅÀåÁúȯÃÖ±Ù±îÁö ¸¸¼º ½ÅÀåÁúȯÀÇ ÁøÇàÀ» Áö¿¬½ÃÅ°´Â È¿°ú¸¦ ÀÔÁõÇÑ ¾à¹° °è¿Àº Ç×°íÇ÷¾ÐÁ¦ ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò¾ïÁ¦Á¦(ACEI)¿Í ¾ÈÁö¿ÀÅٽżö...
THE MOST
|
2020-10-12 15:58
-
1
2
3
4
5
6
-
¿©¹é
Sub
news
¡°Á¹·¹µå·Î³×ÀÌÆ® °ñÀý¿¹¹æ ÀÓ»ó±Ù°Å¡¤ÀûÀÀÁõ ÃÖ´Ù¡±
Q. °ñÀý¿¹¹æÀ» À§ÇÑ ¾à¹°Ä¡·á´Â ¾î¶»°Ô ±Ç°í...
¡°CGM ¿¬µ¿ Àν¶¸°¿ä¹ý °í³µµ ±â¼úÀû Áö½Ä ¿äÇÏ´Â Ä¡·á°úÁ¤¡±
Q. ´ç´¢º´ Ä¡·á½Ã CGM ÀÓ»óÀû ¿ªÇÒÀº?ÀÓ...
¡°·Î¼ö¹Ù½ºÅ¸Æ¾ 20³â ±Ù°Å·Î ¼öÆÛ½ºÅ¸Æ¾ ¸í¼º À¯ÁöÇÒ °Í¡±
Q. ´ç´¢º´ ȯÀÚ¿¡¼ ÁöÁúÄ¡·á°¡ ÇÊ¿äÇÑ ÀÌÀ¯...
¿©¹é
¿©¹é
Back to Top